Showing results (321-330 of 391) with videos related to

Sort By:
Pageof 40
BJGP Open|October 1, 2025
English general practice in a period of change: A mixed methods study of staff and patient perspectivesHeather Gage, Alice Herron, Bridget Jones, et al.
Molecular Cancer Therapeutics|June 22, 2024
Discovery of Monovalent Direct Degraders of BRD4 That Act Via the Recruitment of DCAF11Gregory S Parker, Julia I Toth, Sarah Fish, et al.
Pharmacogenetics and Genomics|April 27, 2017
TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicitySigne Thiesen, Peng Yin, Andrea L Jorgensen, et al.
Acta Neuropathologica|July 13, 2022
Single-cell DNA sequencing identifies risk-associated clonal complexity and evolutionary trajectories in childhood medulloblastoma developmentMarina Danilenko, Masood Zaka, Claire Keeling, et al.
Neuropathology and Applied Neurobiology|April 7, 2021
Advanced molecular pathology for rare tumours: A national feasibility study and model for centralised medulloblastoma diagnosticsStephen Crosier, Debbie Hicks, Edward C Schwalbe, et al.
The Lancet. Child & Adolescent Health|November 23, 2020
Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort studyRebecca M Hill, Stacey Richardson, Edward C Schwalbe, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery and Structural Optimization of BRD4-Selective Monovalent Direct DegradersGeoffray Leriche, Farhana Barmare, Julia I Toth, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|May 25, 2021
Validation of ROS1 by immunohistochemistry against fluorescent in situ hybridisation on cytology and small biopsy samples in a large teaching hospitalNadira Narine, Andrew Wallace, Jonathan Dore, et al.
Cancers|January 11, 2022
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and TreatmentRebecca M Hill, Sabine L A Plasschaert, Beate Timmermann, et al.
Human Molecular Genetics|July 10, 2012
An ancient founder mutation in PROKR2 impairs human reproductionMagdalena Avbelj Stefanija, Marc Jeanpierre, Gerasimos P Sykiotis, et al.
Pageof 40